Adaptive Biotechnologies Corporation Common Stock

AED90.23
AED
Last updated on --.
24h volume2.16M
24h highest93.1397 AED
24h lowest87.5572 AED
24h Price movement-0.37%

ADPT recent prices

24 Hours
-0.37%-AED0.33054
30 days
-1.00%-AED0.90348
60 days
+13.27%+AED10.48
90 days
+45.89%+AED28.48

Key data

Previous close90.5688 AED
Market cap14.77B AED
Volume2.16M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.4691 AED
Net income (FY)-235.02M AED
Revenue (FY)1.13B AED
Last report dateAug 4, 2026

About Adaptive Biotechnologies Corporation Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSEATTLE
Employees (FY)624.00
Revenue per employee (FY)1.81M AED
Net income per employee (FY)-376.63K AED
Listed onNasdaq
Official website

ADPT conversion tables

ADPTADPT
AEDAED
0.5 ADPT45.11 AED
1 ADPT90.23 AED
5 ADPT451.19 AED
10 ADPT902.38 AED
AEDAED
ADPTADPT
0.5 AED0.0055409 ADPT
1 AED0.011082 ADPT
5 AED0.055409 ADPT
10 AED0.11082 ADPT

FAQ

ADPT is trading at AED90.23, -0.37% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ADPT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ADPT is currently trading at AED90.23, -0.37% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ADPT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ADPT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ADPT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ADPT's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Adaptive Biotechnologies Corporation Common Stock's market cap is currently 14.77B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.16M
24h highest93.1397 AED
24h lowest87.5572 AED
24h Price movement-0.37%
ADPTADPT
AEDAED
Start trade with ADPT Perpetual